These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 9367464)
1. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Clark DJ; Lipworth BJ Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464 [TBL] [Abstract][Full Text] [Related]
2. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445 [TBL] [Abstract][Full Text] [Related]
3. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Clark DJ; Grove A; Cargill RI; Lipworth BJ Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128 [TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function. Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385 [TBL] [Abstract][Full Text] [Related]
5. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults. Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029 [TBL] [Abstract][Full Text] [Related]
6. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Wilson AM; McFarlane LC; Lipworth BJ Chest; 1998 Oct; 114(4):1022-7. PubMed ID: 9792571 [TBL] [Abstract][Full Text] [Related]
7. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Lipworth BJ; Clark DJ; McFarlane LC Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of hypothalamic-pituitary-adrenal axis suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid. Ozbek OY; Turktas I; Bakirtas A; Bideci A J Pediatr Endocrinol Metab; 2006 Aug; 19(8):1015-23. PubMed ID: 16995587 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023). Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Nicolaidou P J Pediatr Endocrinol Metab; 2007 Feb; 20(2):261; author reply 261-2. PubMed ID: 17396445 [No Abstract] [Full Text] [Related]
10. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Bacharier LB; Raissy HH; Wilson L; McWilliams B; Strunk RC; Kelly HW Pediatrics; 2004 Jun; 113(6):1693-9. PubMed ID: 15173493 [TBL] [Abstract][Full Text] [Related]
12. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients. Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712 [TBL] [Abstract][Full Text] [Related]
13. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma. Irani AM; Cruz-Rivera M; Fitzpatrick S; Hoag J; Smith JA Ann Allergy Asthma Immunol; 2002 Mar; 88(3):306-12. PubMed ID: 11926625 [TBL] [Abstract][Full Text] [Related]
15. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity. Wilson AM; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799 [TBL] [Abstract][Full Text] [Related]
16. Desmopressin and low-dose ACTH test in rheumatoid arthritis. Foppiani L; Cutolo M; Sessarego P; Sulli A; Prete C; Seriolo B; Giusti M Eur J Endocrinol; 1998 Mar; 138(3):294-301. PubMed ID: 9539304 [TBL] [Abstract][Full Text] [Related]
17. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Clark DJ; Lipworth BJ Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246 [TBL] [Abstract][Full Text] [Related]
18. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311 [TBL] [Abstract][Full Text] [Related]
19. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625 [TBL] [Abstract][Full Text] [Related]
20. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. Nelson HS; Stricker W; Casale TB; Raff H; Fourré JA; Aron DC; Newman KB J Clin Pharmacol; 2002 Mar; 42(3):319-26. PubMed ID: 11865969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]